Skip to content

Edward Carr, Chief Accounting Officer at Dianthus Therapeutics, sold DNTH on Sep 17, 2026

Data as of Oct 16

▼ SELL$796K7,928 shares at $100.43Edward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.
Watch DNTH
Traded
Sep 17, 2026
Disclosed
Sep 18, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Edward Carr, Chief Accounting Officer at Dianthus Therapeutics, sold DNTH on Sep 17, 2026TRADEDDISCLOSED
DNTHSimilar stocks (XLV — its sector index fund), rebased to DNTH's price on the disclosure day
DNTH since disclosure
−25.5%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund

Change in closing price from Sep 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$686Kdisclosed Sep 18 · filed 1 day after the trade
  2. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$114Kdisclosed Sep 18 · filed 1 day after the trade
  3. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$73.1Kdisclosed Sep 18 · filed 1 day after the trade
  4. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$358Kdisclosed Sep 18 · filed 1 day after the trade

See every trade on DNTH →